Technical Analysis for SRPT - Sarepta Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 83.07 -0.49% -0.41
SRPT closed up 0.38 percent on Friday, October 11, 2019, on 48 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Earnings due: Oct 22

*** please verify all earnings dates ***
7 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical SRPT trend table...

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup -0.49%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.49%
NR7 Range Contraction -0.49%
Up 3 Days in a Row Strength -0.49%
Crossed Above 20 DMA Bullish -0.11%
20 DMA Resistance Bearish 2.83%
NR7 Range Contraction 2.83%
20 DMA Resistance Bearish 3.17%
Multiple of Ten Bullish Other 3.17%
Fell Below 20 DMA Bearish 1.79%

Older signals for SRPT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
SRPT Chart by TradingView
Basic chart:
Profile
Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. Its lead product candidate is eteplirsen, an antisense PMO-based therapeutic, which is in Phase IIb clinical development for the treatment of individuals with Duchenne muscular dystrophy. The company is also involved in developing treatments that are in Phase I clinical trials for infectious diseases, including AVI-7288 for Marburg virus; and AVI-7100 for H1N1 influenza virus. In addition, it focuses on developing preclinical research product candidates for the treatment of other neuromuscular, infectious, and rare diseases. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.
Biotechnology Biopharmaceutical Life Sciences Biology Infectious Diseases Rare Diseases Duchenne Muscular Dystrophy Therapeutic Gene Modulation Antisense RNA
Is SRPT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Oct 12 Hedge Funds Have Never Been This Bullish On Sarepta Therapeutics Inc (SRPT)
Oct 11 The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SRPT, TXT and TME
Oct 11 CLASS ACTION UPDATE for SRPT, MGNX and CADE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Oct 11 Burford Capital Limited (BRFRF, BRFRY), Sarepta Therapeutics, Inc. (SRPT), & Canada Goose Holdings Inc. (GOOS) - Bronstein, Gewirtz & Grossman, LLC Reminds of Class Actions
Oct 11 SHAREHOLDER ALERT: SRPT DBX TME: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Oct 11 Burford Capital Limited (BRFRF, BRFRY), Sarepta Therapeutics, Inc. (SRPT), & Canada Goose Holdings Inc. (GOOS) - Class Action - Bronstein, Gewirtz & Grossman, LLC
Oct 10 CLASS ACTION UPDATE for CVS, SRPT and DBX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Oct 10 Burford Capital Limited (BRFRF, BRFRY), Sarepta Therapeutics, Inc. (SRPT), & Canada Goose Holdings Inc. (GOOS) - Class Action Reminder - Bronstein, Gewirtz & Grossman, LLC
Oct 9 The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SRPT, MGNX and UBER
Oct 8 CLASS ACTION UPDATE for PS, IFF, SRPT and SNDL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
See more SRPT news...
Indicators
Indicator Value
52 Week High 158.8
52 Week Low 72.27
Average Volume 1,856,723
200-Day Moving Average 120.5884
50-Day Moving Average 96.5814
20-Day Moving Average 80.701
10-Day Moving Average 80.868
Average True Range 4.4218
ADX 43.7
+DI 20.8853
-DI 26.5272
Chandelier Exit (Long, 3 ATRs ) 77.72459999999999
Chandelier Exit (Short, 3 ATRs ) 85.5354
Upper Bollinger Band 89.0039
Lower Bollinger Band 72.3981
Percent B (%b) 0.67
BandWidth 20.576945
MACD Line -3.5883
MACD Signal Line -5.4702
MACD Histogram 1.8819
Fundamentals Value
Market Cap 5.36 Billion
Num Shares 64.2 Million
EPS -2.34
Price-to-Earnings (P/E) Ratio -35.68
Price-to-Sales 53.98
Price-to-Book 6.98
PEG Ratio 231.25
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 87.13
Resistance 3 (R3) 87.27 86.19 86.52
Resistance 2 (R2) 86.19 85.27 86.12 86.31
Resistance 1 (R1) 84.84 84.69 84.30 84.70 86.11
Pivot Point 83.76 83.76 83.50 83.69 83.76
Support 1 (S1) 82.41 82.84 81.87 82.27 80.85
Support 2 (S2) 81.33 82.26 81.26 80.65
Support 3 (S3) 79.98 81.33 80.44
Support 4 (S4) 79.84